您的位置: 首页 > 2024年4月 第55卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

远程药学管理模式联合延续护理在2型糖尿病合并冠状动脉病变患者居家用药中的研究

Study on home medication of type 2 diabetes patients with coronary artery disease by remote pharmaceutical management mode combined with continuous nursing

来源期刊: 广州医药 | 427-431 发布时间:2024-05-17 收稿时间:2025/11/13 18:49:31 阅读量:33
作者:
关键词:
远程药学管理模式延续性护理T2DM合并冠状动脉病变居家用药
remote pharmaceutical management modecontinuing careT2DM with coronary artery diseasehome medication
DOI:
10.3969/j.issn.1000-8535.2024.04.017
收稿时间:
2023-09-23 
修订日期:
 
接收日期:
 
引用总数:
2  
目的 探讨远程药学管理模式联合延续护理在2型糖尿病(T2DM)合并冠状动脉病变患者居家用药中的应用效果。方法 选取2021年6月—2023年6月在广州医科大学附属第三医院诊治的200例T2DM合并冠状动脉病变患者为研究对象,根据干预方式不同分为常规组100例和研究组100例。常规组患者给予院内院外常规护理,研究组在常规组的基础上给予远程药学管理模式联合延续护理。评估患者用药依从性、饮食依从性、运动依从性、自我管理能力、生活质量[36条目简明健康量表(SF-36)]及心血管事件发生情况。结果 研究组用药、饮食、运动依从性均高于常规组(P<0.05)。相较于干预前,两组患者在干预后的自我管理机能、自我责任感、自我概念及健康知识分值均升高,且研究组高于常规组(P<0.05)。相较于干预前,两组患者在干预后的活力(VT)、精神健康(MH)、情感职能(RE)、躯体疼痛(BP)、生理功能(PF)、社会功能(SF)、生理职能(RP)、总体健康(GH)分值均升高,且研究组高于常规组(P<0.05)。研究组与常规组患者心血管不良事件发生率分别为2例(2.00%)、15例(15.09%),研究组高于常规组(χ2=10.865,P<0.05)。结论 远程药学管理模式联合延续护理能够提高T2DM合并冠状动脉病变患者的用药管理依从性,提高患者自我管理能力,改善生活质量,降低不良心血管事件的发生率。
Objective To explore the application effect of remote pharmacy management mode combined with continuous nursing in the home medication of type 2 diabetes mellitus(T2DM)patients with coronary artery disease.Methods A total of 200 patients with T2DM complicated with coronary artery diseases who were diagnosed and treated in the Third Affiliated Hospital of Guangzhou Medical University from June 2021 to June 2023 were selected as the study subjects.They were divided into a conventional group of 100 patients and a study group of 100 patients based on different intervention methods.The patients in the conventional group received routine care both in and out of the hospital,while the study group received remote pharmaceutical management mode combined with continuous care on the basis of the conventional group.Patient medication compliance,dietary compliance,exercise compliance,self-management ability,quality of life[36 item concise health scale(SF-36)] and incidence of adverse cardiovascular events were assessed.Results The compliance of medication,diet and exercise in the study group were significantly higher than those in the conventional group(P<0.05).Compared to before intervention,the self-management function,sense of responsibility,self-concept and health knowledge scores of both groups of patients were significantly increased after intervention,and the scores of the study group were significantly higher than those in the conventional group(P<0.05).Compared to before intervention,the Vitality(VT),Mental Health(MH),Emotional Function(RE),Physical Pain(BP),Physiological Function(PF),Social Function(SF),Physiological Function(RP)and Overall Health(GH)scores of both groups of patients were significantly increased after intervention,and the scores of the study group was significantly higher than those of the conventional group(P<0.05).The incidence of cardiovascular adverse events in the study group and the conventional group were 2 cases(2.00%)and 15 cases(15.09%),respectively,with the study group significantly higher than the conventional group(χ2=10.865,P<0.05).Conclusions The combination of remote pharmaceutical management mode and continuous care can significantly improve the medication management compliance of T2DM patients with coronary artery disease,improve their self-management ability,improve the quality of their life and reduce the incidence of adverse cardiovascular events.
1、 DESAI A S,MACLEAN T,BLOOD A J,et al.Remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction[J].JAMA Cardiol,2020,5(12):1430-1434. DESAI A S,MACLEAN T,BLOOD A J,et al.Remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction[J].JAMA Cardiol,2020,5(12):1430-1434.
2、 LIN H C,TSENG C W,HSIEH P J,et al.Efficacy of self-management on glucose control in type 2 diabetes mellitus patients treated with insulin[J].Healthcare ,2022,10(10):2080. LIN H C,TSENG C W,HSIEH P J,et al.Efficacy of self-management on glucose control in type 2 diabetes mellitus patients treated with insulin[J].Healthcare ,2022,10(10):2080.
3、 王浩,侯朝铭,高静,等.高血压患者服药依从性影响因素的质性Meta整合[J].护士进修杂志,2023,38(4):360-366. 王浩,侯朝铭,高静,等.高血压患者服药依从性影响因素的质性Meta整合[J].护士进修杂志,2023,38(4):360-366.
4、 PAKKONEN M,STOLT M,CHARALAMBOUS A,et al.Continuing education interventions about person-centered care targeted for nurses in older people long-term care:A systematic review[J].BMC Nurs,2021,20(1):67. PAKKONEN M,STOLT M,CHARALAMBOUS A,et al.Continuing education interventions about person-centered care targeted for nurses in older people long-term care:A systematic review[J].BMC Nurs,2021,20(1):67.
5、 王振苗,孙伯玉,胡洋洋.远程临床药学服务网络平台对老年2 型糖尿病患者用药情况的影响[J].国际老年医学杂志,2023,44(3):280-283. 王振苗,孙伯玉,胡洋洋.远程临床药学服务网络平台对老年2 型糖尿病患者用药情况的影响[J].国际老年医学杂志,2023,44(3):280-283.
6、 田宇红,张径,彭朝胜.远程管理模式在部队原发性高血压患者中的应用[J].中华现代护理杂志,2019,25(26):3360-3362. 田宇红,张径,彭朝胜.远程管理模式在部队原发性高血压患者中的应用[J].中华现代护理杂志,2019,25(26):3360-3362.
7、 PATSOURAS A,FARMAKI P,GARMPI A,et al.Screening and risk assessment of coronary artery disease in patients with type 2 diabetes:An updated review[J].In Vivo,2019 ,33(4):1039-1049. PATSOURAS A,FARMAKI P,GARMPI A,et al.Screening and risk assessment of coronary artery disease in patients with type 2 diabetes:An updated review[J].In Vivo,2019 ,33(4):1039-1049.
8、 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].国际内分泌代谢杂志,2021,41(5):482-548. 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].国际内分泌代谢杂志,2021,41(5):482-548.
9、 王振苗,孙伯玉,胡洋洋.远程药学干预在老年冠心病患者居家用药中的探索[J].国际老年医学杂志,2023,44(2):172-175. 王振苗,孙伯玉,胡洋洋.远程药学干预在老年冠心病患者居家用药中的探索[J].国际老年医学杂志,2023,44(2):172-175.
10、 郝杰,于翰.130例老年2型糖尿病患者长期用药依从性的调查与分析[J].中国医院药学杂志,2019,39(16):1687-1690. 郝杰,于翰.130例老年2型糖尿病患者长期用药依从性的调查与分析[J].中国医院药学杂志,2019,39(16):1687-1690.
11、 GOODARZI M O,ROTTER J I.Genetics insights in the relationship between type 2 diabetes and coronary heart disease[J].Circ Res,2020,126(11):1526-1548. GOODARZI M O,ROTTER J I.Genetics insights in the relationship between type 2 diabetes and coronary heart disease[J].Circ Res,2020,126(11):1526-1548.
12、 ARTASENSI A,PEDRETTI A,VISTOLI G,et al.Type 2 diabetes mellitus:A review of multi-target drugs[J].Molecules,2020,25(8):1987. ARTASENSI A,PEDRETTI A,VISTOLI G,et al.Type 2 diabetes mellitus:A review of multi-target drugs[J].Molecules,2020,25(8):1987.
1、田静,王利,朱永慧.远程药物管理模式对老年冠心病合并2型糖尿病患者医院——家庭过渡期用药偏差的影响[J].中国药物滥用防治杂志,2024,30(11):2035-2037.DOI:10.15900/j.cnki.zylf1995.2024.11.020. 田静,王利,朱永慧.远程药物管理模式对老年冠心病合并2型糖尿病患者医院——家庭过渡期用药偏差的影响[J].中国药物滥用防治杂志,2024,30(11):2035-2037.DOI:10.15900/j.cnki.zylf1995.2024.11.020.
2、张琳,廖容花,赵敏锐,等.家庭药师服务模式在心血管疾病患者中的应用效果及对预后与依从性的影响[J].临床合理用药,2025,18(22):143-146.DOI:10.15887/j.cnki.13-1389/r.2025.22.042. 张琳,廖容花,赵敏锐,等.家庭药师服务模式在心血管疾病患者中的应用效果及对预后与依从性的影响[J].临床合理用药,2025,18(22):143-146.DOI:10.15887/j.cnki.13-1389/r.2025.22.042.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录